{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:16:40Z","timestamp":1790338600273,"version":"4.1.0"},"reference-count":40,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Context.<\/jats:italic>\n                    \u2014Bioterrorism has existed since before the 14th century; however, the specter of such an attack is much greater today than ever before. Technical expertise in microbiology and molecular testing, combined with the rapidity of worldwide air travel, has ensured that no geographic area would be untouched in a widespread attack. Clinical microbiology laboratories will play a pivotal role in the detection of attacks involving weapons of mass destruction.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Objective.<\/jats:italic>\n                    \u2014To identify and discuss the microorganisms most likely to be used as agents of bioterrorism.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Data Sources.<\/jats:italic>\n                    \u2014Data were obtained from literature searches from 1997 through June 2001 using the subject headings of bioterrorism, biological weapons, biological warfare, anthrax, brucellosis, tularemia, smallpox, plague, and botulism. In addition, information was obtained from publications of the Center for Civilian Studies, Johns Hopkins University, the Centers for Disease Control and Prevention, American Society for Microbiology, and the United States Army Medical Research Institute of Infectious Diseases.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Data Extraction and Synthesis.<\/jats:italic>\n                    \u2014Findings obtained from these studies and publications were analyzed for the most likely microorganisms that would be involved in a bioterrorist attack and the most efficient means by which they could be identified. In all instances, the guidelines from the Centers for Disease Control and Prevention for Level A laboratories were observed.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusions.<\/jats:italic>\n                    \u2014The most likely microorganisms to be utilized as biological weapons include\n                    <jats:italic>Bacillus anthracis<\/jats:italic>\n                    (anthrax),\n                    <jats:italic>Brucella<\/jats:italic>\n                    species (brucellosis),\n                    <jats:italic>Clostridium botulinum<\/jats:italic>\n                    (botulism),\n                    <jats:italic>Francisella tularensis<\/jats:italic>\n                    (tularemia),\n                    <jats:italic>Yersinia pestis<\/jats:italic>\n                    (plague), and variola major (smallpox). While knowledge of the potential of these microorganisms is critical, clinical microbiologists and medical technologists possess the basic tools to rule out the suspected pathogens or to refer these isolates to public health laboratories for identification and susceptibility testing.\n                  <\/jats:p>","DOI":"10.5858\/2002-126-0291-tmlsri","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T03:05:33Z","timestamp":1611889533000},"page":"291-294","source":"Crossref","is-referenced-by-count":41,"title":["The Microbiology Laboratory's Role in Response to Bioterrorism"],"prefix":"10.5858","volume":"126","author":[{"given":"Barbara","family":"Robinson-Dunn","sequence":"first","affiliation":[{"name":"From the Section of Microbiology, Michigan Department of Community Health, Lansing, Mich. Dr Robinson-Dunn is now with the Department of Clinical Pathology, William Beaumont Hospital, Royal Oak, Mich"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"key":"i1543-2165-126-3-291-b1","series-title":"JAMA","first-page":"412","article-title":"Biological warfare: a historical perspective.","volume":"278","author":"Christopher, G. W.","year":"1997","unstructured":"Christopher, G. W., T. J.Cieslak, and J. A.Pavlin. et al. Biological warfare: a historical perspective.JAMA1997. 278:412\u2013417."},{"key":"i1543-2165-126-3-291-b2","article-title":"Laboratory safety, management and diagnosis of biological agents associated with bioterrorism.","author":"Gilchrist, M. J. R.","unstructured":"Gilchrist, M. J. R., W. P.McKinney, J. M.Miller, and A. S.Weissfeld. Laboratory safety, management and diagnosis of biological agents associated with bioterrorism.In: Snyder JW, coordinating editor. Cumitech 33. Washington, DC: ASM Press; 2000:1\u201319."},{"key":"i1543-2165-126-3-291-b3","series-title":"Emerg Infect Dis","first-page":"523","article-title":"Potential biological weapons threats.","volume":"5","author":"Kortepeter, M. G.","year":"1999","unstructured":"Kortepeter, M. G. and G. W.Parker. Potential biological weapons threats.Emerg Infect Dis1999. 5:523\u2013527."},{"key":"i1543-2165-126-3-291-b4","article-title":"Bioterrorism Threats to Our Future: The Role of the Clinical Microbiology Laboratory in Detection, Identification, and Confirmation of Biological Agents.","author":"Snyder, J. W.","unstructured":"Snyder, J. W. and W.Check. Bioterrorism Threats to Our Future: The Role of the Clinical Microbiology Laboratory in Detection, Identification, and Confirmation of Biological Agents.Washington, DC: American Academy of Microbiology and College of Microbiology, American Society for Microbiology; 2001."},{"key":"i1543-2165-126-3-291-b5","article-title":"Biosafety in Microbiological and Biomedical Laboratories. 4th ed.","unstructured":"US Department of Health and Human Services.\n          \n          Biosafety in Microbiological and Biomedical Laboratories. 4th ed.\n          Washington, DC: US Government Printing Office; 1999."},{"key":"i1543-2165-126-3-291-b6","series-title":"Emerg Infect Dis","first-page":"552","article-title":"Clinical and epidemiologic principles of anthrax.","volume":"5","author":"Cieslak, T. J.","year":"1999","unstructured":"Cieslak, T. J. and E. M.Eitzen. Clinical and epidemiologic principles of anthrax.Emerg Infect Dis1999. 5:552\u2013555."},{"key":"i1543-2165-126-3-291-b7","series-title":"JAMA","first-page":"1735","article-title":"for the Working Group on Civilian Biodefense. Anthrax as a biological weapon: medical and public health management.","volume":"281","author":"Inglesby, T. V.","year":"1999","unstructured":"Inglesby, T. V., D. A.Henderson, and J. G.Bartlett. et al,. for the Working Group on Civilian Biodefense. Anthrax as a biological weapon: medical and public health management.JAMA1999. 281:1735\u20131745."},{"key":"i1543-2165-126-3-291-b8","article-title":"Bacillus and recently derived genera.","author":"Logan, N. A.","unstructured":"Logan, N. A. and P. C.Turnbull. Bacillus and recently derived genera.In: Murray PR, Baron EJ, Pfaller MA, Tenover RC, Yolken RH, eds. Manual of Clinical Microbiology. 7th ed. Washington, DC: American Society for Microbiology; 1999:357\u2013369."},{"key":"i1543-2165-126-3-291-b9","series-title":"JAMA","first-page":"2281","article-title":"for the Working Group on Civilian Biodefense. Plague as a biological weapon: medical and public health management.","volume":"283","author":"Inglesby, T. B.","year":"2000","unstructured":"Inglesby, T. B., D. T.Dennis, and D. A.Henderson. et al,. for the Working Group on Civilian Biodefense. Plague as a biological weapon: medical and public health management.JAMA2000. 283:2281\u20132290."},{"key":"i1543-2165-126-3-291-b10","article-title":"Yersinia and other Enterobacteriaceae.","author":"Aleksic, S.","unstructured":"Aleksic, S. and J.Bockemuhl. Yersinia and other Enterobacteriaceae.In: Murray PR, Baron EJ, Pfaller MA, Tenover RC, Yolken RH, eds. Manual of Clinical Microbiology. 7th ed. Washington, DC: American Society for Microbiology; 1999:483\u2013496."},{"key":"i1543-2165-126-3-291-b11","series-title":"JAMA","first-page":"2763","article-title":"Tularemia as a biological weapon: medical and public health management.","volume":"285","author":"Dennis, D. T.","year":"2001","unstructured":"Dennis, D. T., T. V.Inglesby, and D. A.Henderson. et al, for the Working Group on Civilian Biodefense. Tularemia as a biological weapon: medical and public health management.JAMA2001. 285:2763\u20132773."},{"key":"i1543-2165-126-3-291-b12","article-title":"Francisella.","author":"Wong, J. D.","unstructured":"Wong, J. D. and D. S.Shapiro. Francisella.In: Murray PR, Baron EJ, Pfaller MA, Tenover RC, Yolken RH, eds. Manual of Clinical Microbiology. 7th ed. Washington, DC: American Society for Microbiology; 1999:647\u2013651."},{"key":"i1543-2165-126-3-291-b13","series-title":"Clin Infect Dis","first-page":"283","article-title":"An overview of human brucellosis.","volume":"21","author":"Young, E. J.","year":"1995","unstructured":"Young, E. J.\n          \n          An overview of human brucellosis.\n          Clin Infect Dis\n          1995. 21:283\u2013290."},{"key":"i1543-2165-126-3-291-b14","article-title":"Brucella.","author":"Shapiro, D. S.","unstructured":"Shapiro, D. S. and J. D.Wong. Brucella.In: Murray PR, Baron EJ, Pfaller MA, Tenover RC, Yolken RH, eds. Manual of Clinical Microbiology. 7th ed. Washington, DC: American Society for Microbiology; 1999:625\u2013631."},{"key":"i1543-2165-126-3-291-b15","series-title":"Emerg Infect Dis","first-page":"537","article-title":"Smallpox: clinical and epidemiologic features.","volume":"5","author":"Henderson, D. A.","year":"1999","unstructured":"Henderson, D. A.\n          \n          Smallpox: clinical and epidemiologic features.\n          Emerg Infect Dis\n          1999. 5:537\u2013539."},{"key":"i1543-2165-126-3-291-b16","article-title":"Biological warfare and terrorism: medical issues and response.","unstructured":"US Army Medical Research Institute.\n          \n          Biological warfare and terrorism: medical issues and response.\n          Frederick, Md: US Army Medical Research Institute of Infectious Diseases; 2000."},{"key":"i1543-2165-126-3-291-b17","series-title":"Clin Microbiol Rev","first-page":"364","article-title":"Bioterrorism: implications for the clinical microbiologist.","volume":"14","author":"Klietmann, W. F.","year":"2001","unstructured":"Klietmann, W. F. and K. L.Ruoff. Bioterrorism: implications for the clinical microbiologist.Clin Microbiol Rev2001. 14:364\u2013381."},{"key":"i1543-2165-126-3-291-b18","series-title":"JAMA","first-page":"1059","article-title":"for the Working Group on Civilian Biodefense. Botulinum toxin as a biological weapon: medical and public health management.","volume":"285","author":"Arnon, S. S.","year":"2001","unstructured":"Arnon, S. S., R.Schechter, and T. V.Inglesby. et al,. for the Working Group on Civilian Biodefense. Botulinum toxin as a biological weapon: medical and public health management.JAMA2001. 285:1059\u20131070."},{"key":"i1543-2165-126-3-291-b19","article-title":"Laboratory Safety: Principles and Practices. 2nd ed.","author":"Fleming, D. O.","unstructured":"Fleming, D. O., J. H.Richardson, J. J.Tulis, and D.Vesley. eds. Laboratory Safety: Principles and Practices. 2nd ed.Washington, DC: American Society for Microbiology; 1995."},{"key":"i1543-2165-126-3-291-b20","article-title":"Botulism in the United States, 1899\u20131996: Handbook for Epidemiologists, Clinicians and Laboratory Workers.","unstructured":"Centers for Disease Control and Prevention.\n          \n          Botulism in the United States, 1899\u20131996: Handbook for Epidemiologists, Clinicians and Laboratory Workers.\n          Atlanta, Ga: Centers for Disease Control and Prevention; 1998."},{"key":"i1543-2165-126-3-291-b1","series-title":"JAMA","first-page":"412","article-title":"Biological warfare: a historical perspective.","volume":"278","author":"Christopher, G. W.","year":"1997","unstructured":"Christopher, G. W., T. J.Cieslak, and J. A.Pavlin. et al. Biological warfare: a historical perspective.JAMA1997. 278:412\u2013417."},{"key":"i1543-2165-126-3-291-b2","article-title":"Laboratory safety, management and diagnosis of biological agents associated with bioterrorism.","author":"Gilchrist, M. J. R.","unstructured":"Gilchrist, M. J. R., W. P.McKinney, J. M.Miller, and A. S.Weissfeld. Laboratory safety, management and diagnosis of biological agents associated with bioterrorism.In: Snyder JW, coordinating editor. Cumitech 33. Washington, DC: ASM Press; 2000:1\u201319."},{"key":"i1543-2165-126-3-291-b3","series-title":"Emerg Infect Dis","first-page":"523","article-title":"Potential biological weapons threats.","volume":"5","author":"Kortepeter, M. G.","year":"1999","unstructured":"Kortepeter, M. G. and G. W.Parker. Potential biological weapons threats.Emerg Infect Dis1999. 5:523\u2013527."},{"key":"i1543-2165-126-3-291-b4","article-title":"Bioterrorism Threats to Our Future: The Role of the Clinical Microbiology Laboratory in Detection, Identification, and Confirmation of Biological Agents.","author":"Snyder, J. W.","unstructured":"Snyder, J. W. and W.Check. Bioterrorism Threats to Our Future: The Role of the Clinical Microbiology Laboratory in Detection, Identification, and Confirmation of Biological Agents.Washington, DC: American Academy of Microbiology and College of Microbiology, American Society for Microbiology; 2001."},{"key":"i1543-2165-126-3-291-b5","article-title":"Biosafety in Microbiological and Biomedical Laboratories. 4th ed.","unstructured":"US Department of Health and Human Services.\n          \n          Biosafety in Microbiological and Biomedical Laboratories. 4th ed.\n          Washington, DC: US Government Printing Office; 1999."},{"key":"i1543-2165-126-3-291-b6","series-title":"Emerg Infect Dis","first-page":"552","article-title":"Clinical and epidemiologic principles of anthrax.","volume":"5","author":"Cieslak, T. J.","year":"1999","unstructured":"Cieslak, T. J. and E. M.Eitzen. Clinical and epidemiologic principles of anthrax.Emerg Infect Dis1999. 5:552\u2013555."},{"key":"i1543-2165-126-3-291-b7","series-title":"JAMA","first-page":"1735","article-title":"for the Working Group on Civilian Biodefense. Anthrax as a biological weapon: medical and public health management.","volume":"281","author":"Inglesby, T. V.","year":"1999","unstructured":"Inglesby, T. V., D. A.Henderson, and J. G.Bartlett. et al,. for the Working Group on Civilian Biodefense. Anthrax as a biological weapon: medical and public health management.JAMA1999. 281:1735\u20131745."},{"key":"i1543-2165-126-3-291-b8","article-title":"Bacillus and recently derived genera.","author":"Logan, N. A.","unstructured":"Logan, N. A. and P. C.Turnbull. Bacillus and recently derived genera.In: Murray PR, Baron EJ, Pfaller MA, Tenover RC, Yolken RH, eds. Manual of Clinical Microbiology. 7th ed. Washington, DC: American Society for Microbiology; 1999:357\u2013369."},{"key":"i1543-2165-126-3-291-b9","series-title":"JAMA","first-page":"2281","article-title":"for the Working Group on Civilian Biodefense. Plague as a biological weapon: medical and public health management.","volume":"283","author":"Inglesby, T. B.","year":"2000","unstructured":"Inglesby, T. B., D. T.Dennis, and D. A.Henderson. et al,. for the Working Group on Civilian Biodefense. Plague as a biological weapon: medical and public health management.JAMA2000. 283:2281\u20132290."},{"key":"i1543-2165-126-3-291-b10","article-title":"Yersinia and other Enterobacteriaceae.","author":"Aleksic, S.","unstructured":"Aleksic, S. and J.Bockemuhl. Yersinia and other Enterobacteriaceae.In: Murray PR, Baron EJ, Pfaller MA, Tenover RC, Yolken RH, eds. Manual of Clinical Microbiology. 7th ed. Washington, DC: American Society for Microbiology; 1999:483\u2013496."},{"key":"i1543-2165-126-3-291-b11","series-title":"JAMA","first-page":"2763","article-title":"Tularemia as a biological weapon: medical and public health management.","volume":"285","author":"Dennis, D. T.","year":"2001","unstructured":"Dennis, D. T., T. V.Inglesby, and D. A.Henderson. et al, for the Working Group on Civilian Biodefense. Tularemia as a biological weapon: medical and public health management.JAMA2001. 285:2763\u20132773."},{"key":"i1543-2165-126-3-291-b12","article-title":"Francisella.","author":"Wong, J. D.","unstructured":"Wong, J. D. and D. S.Shapiro. Francisella.In: Murray PR, Baron EJ, Pfaller MA, Tenover RC, Yolken RH, eds. Manual of Clinical Microbiology. 7th ed. Washington, DC: American Society for Microbiology; 1999:647\u2013651."},{"key":"i1543-2165-126-3-291-b13","series-title":"Clin Infect Dis","first-page":"283","article-title":"An overview of human brucellosis.","volume":"21","author":"Young, E. J.","year":"1995","unstructured":"Young, E. J.\n          \n          An overview of human brucellosis.\n          Clin Infect Dis\n          1995. 21:283\u2013290."},{"key":"i1543-2165-126-3-291-b14","article-title":"Brucella.","author":"Shapiro, D. S.","unstructured":"Shapiro, D. S. and J. D.Wong. Brucella.In: Murray PR, Baron EJ, Pfaller MA, Tenover RC, Yolken RH, eds. Manual of Clinical Microbiology. 7th ed. Washington, DC: American Society for Microbiology; 1999:625\u2013631."},{"key":"i1543-2165-126-3-291-b15","series-title":"Emerg Infect Dis","first-page":"537","article-title":"Smallpox: clinical and epidemiologic features.","volume":"5","author":"Henderson, D. A.","year":"1999","unstructured":"Henderson, D. A.\n          \n          Smallpox: clinical and epidemiologic features.\n          Emerg Infect Dis\n          1999. 5:537\u2013539."},{"key":"i1543-2165-126-3-291-b16","article-title":"Biological warfare and terrorism: medical issues and response.","unstructured":"US Army Medical Research Institute.\n          \n          Biological warfare and terrorism: medical issues and response.\n          Frederick, Md: US Army Medical Research Institute of Infectious Diseases; 2000."},{"key":"i1543-2165-126-3-291-b17","series-title":"Clin Microbiol Rev","first-page":"364","article-title":"Bioterrorism: implications for the clinical microbiologist.","volume":"14","author":"Klietmann, W. F.","year":"2001","unstructured":"Klietmann, W. F. and K. L.Ruoff. Bioterrorism: implications for the clinical microbiologist.Clin Microbiol Rev2001. 14:364\u2013381."},{"key":"i1543-2165-126-3-291-b18","series-title":"JAMA","first-page":"1059","article-title":"for the Working Group on Civilian Biodefense. Botulinum toxin as a biological weapon: medical and public health management.","volume":"285","author":"Arnon, S. S.","year":"2001","unstructured":"Arnon, S. S., R.Schechter, and T. V.Inglesby. et al,. for the Working Group on Civilian Biodefense. Botulinum toxin as a biological weapon: medical and public health management.JAMA2001. 285:1059\u20131070."},{"key":"i1543-2165-126-3-291-b19","article-title":"Laboratory Safety: Principles and Practices. 2nd ed.","author":"Fleming, D. O.","unstructured":"Fleming, D. O., J. H.Richardson, J. J.Tulis, and D.Vesley. eds. Laboratory Safety: Principles and Practices. 2nd ed.Washington, DC: American Society for Microbiology; 1995."},{"key":"i1543-2165-126-3-291-b20","article-title":"Botulism in the United States, 1899\u20131996: Handbook for Epidemiologists, Clinicians and Laboratory Workers.","unstructured":"Centers for Disease Control and Prevention.\n          \n          Botulism in the United States, 1899\u20131996: Handbook for Epidemiologists, Clinicians and Laboratory Workers.\n          Atlanta, Ga: Centers for Disease Control and Prevention; 1998."}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/126\/3\/article-p291.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/126\/3\/291\/2728505\/0003-9985(2002)126_0291_tmlsri_2_0_co_2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/126\/3\/article-p291.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/126\/3\/article-p291.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:04:36Z","timestamp":1770771876000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/126\/3\/article-p291.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":40,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.5858\/2002-126-0291-tmlsri","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}